Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Vida Life International Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vida Life International Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Vimta Labs Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vimta Labs Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Vindon Healthcare Plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vindon Healthcare Plc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

VioQuest Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

VioQuest Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Viral Genetics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Viral Genetics Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Viralytics Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Viralytics Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Prescient Therapeutics Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Prescient Therapeutics Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Virbac SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Virbac SA Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

ViroMed Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ViroMed Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

ViroPharma Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ViroPharma Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Viropro Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Viropro Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

VirtualScopics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

VirtualScopics Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Vista Pharmaceuticals Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vista Pharmaceuticals Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Vita Life Sciences Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vita Life Sciences Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Vital Group Holdings Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vital Group Holdings Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Vitro Diagnostics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vitro Diagnostics, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Vitrolife Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vitrolife Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Viva China Holdings Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Viva China Holdings Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Vivakor, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vivakor, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Vivalis SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vivalis SA Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

VIVUS Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

VIVUS Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

VMT Scientific Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

VMT Scientific Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

WaferGen Biosystems, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

WaferGen Biosystems, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Wai Yuen Tong Medicine Holdings Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Wai Yuen Tong Medicine Holdings Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Wakamoto Pharmaceutical Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Wakamoto Pharmaceutical Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Walvax Biotechnology Co.,Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Walvax Biotechnology Co.,Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Wanbury Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Wanbury Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Warner Chilcott plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Warner Chilcott plc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Warnex Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Warnex Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Waters Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Waters Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Watson Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Watson Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

WayPoint Biomedical Holdings, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

WayPoint Biomedical Holdings, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Welcure Drugs & Pharmaceuticals Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Welcure Drugs & Pharmaceuticals Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Welichem Biotech Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Welichem Biotech Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Wex Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Wex Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Whanin Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Whanin Pharmaceutical Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Wilex AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Wilex AG Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

William Ransom & Son plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

William Ransom & Son plc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Winston Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Winston Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Wintac Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Wintac Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Wockhardt Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Wockhardt Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

WooGene B&G Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

WooGene B&G Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Wool Equities Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Wool Equities Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Wooridul Life Sciences Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Wooridul Life Sciences Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Wooridul Pharmaceutical Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Wooridul Pharmaceutical Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Worldwide Biotech & Pharmaceutical Company Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Worldwide Biotech & Pharmaceutical Company Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Wuhan Humanwell Hi-tech Industry Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Wuhan Humanwell Hi-tech Industry Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Wuhan Jianmin Pharmaceutical Group Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Wuhan Jianmin Pharmaceutical Group Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Wuhan National Pharmaceutical Technology Company Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Wuhan National Pharmaceutical Technology Company Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

WuXi PharmaTech (Cayman) Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

WuXi PharmaTech (Cayman) Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Filters

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1